Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

Clinical trial NCT01585766 · COMPLETED

Trial details

NCT number: NCT01585766
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing Forms

Start date: 2012-04-24
Primary completion: 2015-01-02
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.